Shares of Perrigo (PRGO) - Get Report were lower by 5.6% to $71.96 in early trading on Wednesday morning, after the company disclosed late Tuesday night that search warrants had been executed at its corporate offices with regards to an ongoing Department of Justice Antitrust Division investigation.
The investigation is in relation to drug pricing in the pharmaceutical industry.
"As has been previously disclosed by a number of companies, the Antitrust Division has been looking at industry-wide pricing practices. The company is taking this investigation seriously and is cooperating with the appropriate authorities," the company said.
Shares of generic drugmakers plunged Nov. 3 on press reports that the U.S. Department of Justice was on the verge of issuing criminal charges for suspected price collusion.
The DOJ's investigation has been under way for at least two years and a number of companies have reported receiving subpoenas related to the investigation.
Shares of companies that had announced investigations and others thought subject to the investigation were hit at the time, including Mylan (MYL) - Get Report ,Teva (TEVA) - Get ReportEndo (ENDP) - Get Report , Lannett (LCI) - Get Report , Impax Laboratories (IPXL) and Taro Pharmaceutical (TARO) - Get Report .
Read More Trending Articles:
- No Gilead Sciences M&A Yet, but CEO Offers Hint of Deals to Come
- This Is Why You Would Be Really Insane to Sell Apple
- Apple's Quarterly Disappointment Weighs on Wall Street
- Twitter Stock Jumps After Mark Cuban Buys Shares
- Apple's Earnings Were Pretty Healthy, Except for in One Important Country